Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodene
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 38 (4), 477-486
- https://doi.org/10.1016/0010-7824(88)90088-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 150 μg desogestrelContraception, 1988
- The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in womenContraception, 1985
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- The pharmacokinetics of levonorgestrel and ethynylestradiol in women — Studies with ovran and ovranetteContraception, 1981
- Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hormone binding globulinThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Kinetics of norethindrone in women; I. Radioimmunoassay and concentrations during multiple dosingClinical Pharmacology & Therapeutics, 1978
- Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in womenContraception, 1978
- Plasma concentrations of ethinylestradiol and d-norgestrel during two immediate postabortal oral contraceptive cyclesContraception, 1978
- Sex Hormone Binding Globulin : The Carrier Protein For d-NorgestrelJournal of Clinical Endocrinology & Metabolism, 1976
- SEX‐HORMONE‐BINDING GLOBULINClinical Endocrinology, 1974